| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonuclease III activity | 1.69e-05 | 3 | 48 | 2 | GO:0004525 | |
| GeneOntologyMolecularFunction | double-stranded RNA-specific ribonuclease activity | 1.69e-05 | 3 | 48 | 2 | GO:0032296 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 1.57e-04 | 8 | 48 | 2 | GO:0043237 | |
| GeneOntologyMolecularFunction | siRNA binding | 3.68e-04 | 12 | 48 | 2 | GO:0035197 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 4.34e-04 | 13 | 48 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 5.13e-04 | 65 | 48 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 5.82e-04 | 15 | 48 | 2 | GO:0005005 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 7.20e-04 | 73 | 48 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 9.43e-04 | 19 | 48 | 2 | GO:0005003 | |
| GeneOntologyMolecularFunction | SUMO binding | 9.43e-04 | 19 | 48 | 2 | GO:0032183 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.12e-03 | 85 | 48 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 1.94e-03 | 372 | 48 | 5 | GO:0061630 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 2.20e-03 | 29 | 48 | 2 | GO:0043395 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 2.60e-03 | 398 | 48 | 5 | GO:0061659 | |
| GeneOntologyMolecularFunction | laminin binding | 3.02e-03 | 34 | 48 | 2 | GO:0043236 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.57e-03 | 37 | 48 | 2 | GO:0016891 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell development | 2.00e-05 | 69 | 48 | 4 | GO:0002066 | |
| GeneOntologyBiologicalProcess | intestinal epithelial cell development | 2.31e-05 | 24 | 48 | 3 | GO:0060576 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 2.31e-05 | 24 | 48 | 3 | GO:0031290 | |
| GeneOntologyBiologicalProcess | digestive tract development | 2.70e-05 | 152 | 48 | 5 | GO:0048565 | |
| GeneOntologyBiologicalProcess | digestive system development | 4.23e-05 | 167 | 48 | 5 | GO:0055123 | |
| GeneOntologyBiologicalProcess | central nervous system projection neuron axonogenesis | 5.59e-05 | 32 | 48 | 3 | GO:0021952 | |
| GeneOntologyBiologicalProcess | tube development | EPHB3 TYMS SLIT2 KIF18A PXDN DPPA4 LRP2 TLR9 STIL DICER1 ALX4 EPHB1 | 6.52e-05 | 1402 | 48 | 12 | GO:0035295 |
| GeneOntologyBiologicalProcess | intestinal epithelial cell differentiation | 6.73e-05 | 34 | 48 | 3 | GO:0060575 | |
| GeneOntologyBiologicalProcess | male sex differentiation | 9.72e-05 | 199 | 48 | 5 | GO:0046661 | |
| GeneOntologyBiologicalProcess | central nervous system neuron axonogenesis | 1.37e-04 | 43 | 48 | 3 | GO:0021955 | |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 1.46e-04 | 217 | 48 | 5 | GO:0021953 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 2.50e-04 | 383 | 48 | 6 | GO:0048608 | |
| GeneOntologyBiologicalProcess | sensory organ development | 2.55e-04 | 730 | 48 | 8 | GO:0007423 | |
| GeneOntologyBiologicalProcess | reproductive system development | 2.68e-04 | 388 | 48 | 6 | GO:0061458 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 3.94e-04 | 269 | 48 | 5 | GO:0002064 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 3.99e-04 | 418 | 48 | 6 | GO:0051962 | |
| GeneOntologyCellularComponent | dendrite | 5.91e-04 | 858 | 47 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 6.00e-04 | 860 | 47 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | extracellular matrix | 6.13e-04 | 656 | 47 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 6.24e-04 | 658 | 47 | 7 | GO:0030312 | |
| Domain | NPIP | 2.70e-10 | 14 | 52 | 5 | IPR009443 | |
| Domain | EGF-like_CS | 7.51e-06 | 261 | 52 | 7 | IPR013032 | |
| Domain | EGF_2 | 8.30e-06 | 265 | 52 | 7 | PS01186 | |
| Domain | Ribonuclease_3 | 2.28e-05 | 3 | 52 | 2 | PF00636 | |
| Domain | RIBOc | 2.28e-05 | 3 | 52 | 2 | SM00535 | |
| Domain | RNase_III_dom | 2.28e-05 | 3 | 52 | 2 | IPR000999 | |
| Domain | RNASE_3_1 | 2.28e-05 | 3 | 52 | 2 | PS00517 | |
| Domain | RNASE_3_2 | 2.28e-05 | 3 | 52 | 2 | PS50142 | |
| Domain | - | 2.28e-05 | 3 | 52 | 2 | 1.10.1520.10 | |
| Domain | EGF | 2.60e-05 | 126 | 52 | 5 | PF00008 | |
| Domain | EGF | 4.67e-05 | 235 | 52 | 6 | SM00181 | |
| Domain | - | 5.04e-05 | 73 | 52 | 4 | 2.60.120.260 | |
| Domain | EGF-like_dom | 6.44e-05 | 249 | 52 | 6 | IPR000742 | |
| Domain | EGF_1 | 7.35e-05 | 255 | 52 | 6 | PS00022 | |
| Domain | Galactose-bd-like | 1.35e-04 | 94 | 52 | 4 | IPR008979 | |
| Domain | zf-RING_2 | 4.09e-04 | 52 | 52 | 3 | PF13639 | |
| Domain | LRR_6 | 4.82e-04 | 55 | 52 | 3 | PF13516 | |
| Domain | EGF_3 | 4.85e-04 | 235 | 52 | 5 | PS50026 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 6.77e-04 | 14 | 52 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 6.77e-04 | 14 | 52 | 2 | PS00790 | |
| Domain | Eph_TM | 6.77e-04 | 14 | 52 | 2 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 6.77e-04 | 14 | 52 | 2 | IPR001426 | |
| Domain | EPH_lbd | 6.77e-04 | 14 | 52 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 6.77e-04 | 14 | 52 | 2 | PF01404 | |
| Domain | TIL_dom | 6.77e-04 | 14 | 52 | 2 | IPR002919 | |
| Domain | EphA2_TM | 6.77e-04 | 14 | 52 | 2 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 6.77e-04 | 14 | 52 | 2 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 6.77e-04 | 14 | 52 | 2 | IPR001090 | |
| Domain | EPH_LBD | 6.77e-04 | 14 | 52 | 2 | PS51550 | |
| Domain | Leu-rich_rpt | 9.23e-04 | 271 | 52 | 5 | IPR001611 | |
| Domain | Growth_fac_rcpt_ | 9.28e-04 | 156 | 52 | 4 | IPR009030 | |
| Domain | DSRM | 1.26e-03 | 19 | 52 | 2 | SM00358 | |
| Domain | LRR_8 | 1.30e-03 | 171 | 52 | 4 | PF13855 | |
| Domain | Znf_C3HC4_RING-type | 1.33e-03 | 172 | 52 | 4 | IPR018957 | |
| Domain | dsrm | 1.40e-03 | 20 | 52 | 2 | PF00035 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.48e-03 | 177 | 52 | 4 | IPR003591 | |
| Domain | LRR_TYP | 1.48e-03 | 177 | 52 | 4 | SM00369 | |
| Domain | DS_RBD | 1.54e-03 | 21 | 52 | 2 | PS50137 | |
| Domain | - | 1.95e-03 | 321 | 52 | 5 | 3.80.10.10 | |
| Domain | L_dom-like | 2.14e-03 | 328 | 52 | 5 | IPR032675 | |
| Domain | Ephrin_rec_like | 2.19e-03 | 25 | 52 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 2.19e-03 | 25 | 52 | 2 | IPR011641 | |
| Domain | LRR | 2.35e-03 | 201 | 52 | 4 | PS51450 | |
| Domain | EGF_Ca-bd_CS | 2.50e-03 | 97 | 52 | 3 | IPR018097 | |
| Domain | - | 2.55e-03 | 27 | 52 | 2 | 3.30.160.20 | |
| Domain | LRRNT | 2.57e-03 | 98 | 52 | 3 | IPR000372 | |
| Domain | LRRNT | 2.57e-03 | 98 | 52 | 3 | SM00013 | |
| Domain | EGF_CA | 2.64e-03 | 99 | 52 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.72e-03 | 100 | 52 | 3 | PS00010 | |
| Domain | dsRBD_dom | 2.74e-03 | 28 | 52 | 2 | IPR014720 | |
| Domain | LRR_1 | 3.21e-03 | 219 | 52 | 4 | PF00560 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.21e-03 | 106 | 52 | 3 | IPR000152 | |
| Domain | zf-C3HC4 | 3.42e-03 | 223 | 52 | 4 | PF00097 | |
| Domain | VWFC_1 | 4.51e-03 | 36 | 52 | 2 | PS01208 | |
| Domain | EGF_CA | 4.76e-03 | 122 | 52 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.98e-03 | 124 | 52 | 3 | IPR001881 | |
| Domain | VWC | 5.01e-03 | 38 | 52 | 2 | SM00214 | |
| Domain | VWFC_2 | 5.01e-03 | 38 | 52 | 2 | PS50184 | |
| Pathway | WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS | 9.99e-05 | 6 | 37 | 2 | M39578 | |
| Pathway | WP_MIRNA_BIOGENESIS | 9.99e-05 | 6 | 37 | 2 | M39416 | |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 4.80e-12 | 4 | 53 | 4 | 18055785 | |
| Pubmed | Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism. | 5.47e-07 | 11 | 53 | 3 | 19515977 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26718009 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26906421 | ||
| Pubmed | Impact of DICER1 and DROSHA on the Angiogenic Capacity of Human Endothelial Cells. | 2.28e-06 | 2 | 53 | 2 | 34576018 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22479364 | ||
| Pubmed | Upregulation of microRNA processing enzymes Drosha and Dicer in gestational diabetes mellitus. | 2.28e-06 | 2 | 53 | 2 | 25295740 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 34287278 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 32894467 | ||
| Pubmed | The effects of DICER1 and DROSHA polymorphisms on susceptibility to recurrent spontaneous abortion. | 2.28e-06 | 2 | 53 | 2 | 31659796 | |
| Pubmed | Dicer, Drosha, and outcomes in patients with ovarian cancer. | 2.28e-06 | 2 | 53 | 2 | 19092150 | |
| Pubmed | Dysregulated expression of dicer and drosha in breast cancer. | 2.28e-06 | 2 | 53 | 2 | 21898071 | |
| Pubmed | Positive selection of a gene family during the emergence of humans and African apes. | 2.28e-06 | 2 | 53 | 2 | 11586358 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24725360 | ||
| Pubmed | Expression of DROSHA and DICER genes in peripheral blood leukocytes in lung sarcoidosis. | 2.28e-06 | 2 | 53 | 2 | 30701851 | |
| Pubmed | siRNA release from pri-miRNA scaffolds is controlled by the sequence and structure of RNA. | 2.28e-06 | 2 | 53 | 2 | 26921501 | |
| Pubmed | Alternative initiation and splicing in dicer gene expression in human breast cells. | 2.28e-06 | 2 | 53 | 2 | 15987463 | |
| Pubmed | Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. | 2.28e-06 | 2 | 53 | 2 | 18434510 | |
| Pubmed | Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins. | 2.28e-06 | 2 | 53 | 2 | 28448850 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23266047 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 31013297 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23349018 | ||
| Pubmed | Sequence features of Drosha and Dicer cleavage sites affect the complexity of isomiRs. | 2.28e-06 | 2 | 53 | 2 | 25867481 | |
| Pubmed | TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis. | 2.28e-06 | 2 | 53 | 2 | 21439959 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 25190313 | ||
| Pubmed | DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases. | 2.28e-06 | 2 | 53 | 2 | 27808570 | |
| Pubmed | Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. | 2.28e-06 | 2 | 53 | 2 | 20210522 | |
| Pubmed | Murine follicular development requires oocyte DICER, but not DROSHA. | 2.28e-06 | 2 | 53 | 2 | 24990804 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33535080 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 37099569 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 21544061 | ||
| Pubmed | Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer. | 2.28e-06 | 2 | 53 | 2 | 21559780 | |
| Pubmed | Dynamic microRNA gene transcription and processing during T cell development. | 2.28e-06 | 2 | 53 | 2 | 22379031 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26156018 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17060477 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29892896 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22381205 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20805302 | ||
| Pubmed | The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. | 2.28e-06 | 2 | 53 | 2 | 21953080 | |
| Pubmed | 2.68e-06 | 18 | 53 | 3 | 16854408 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 25439752 | ||
| Pubmed | MicroRNA binding to the HIV-1 Gag protein inhibits Gag assembly and virus production. | 6.83e-06 | 3 | 53 | 2 | 24938790 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 25656609 | ||
| Pubmed | Drosha regulates neurogenesis by controlling neurogenin 2 expression independent of microRNAs. | 6.83e-06 | 3 | 53 | 2 | 22706270 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 31250375 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 24769857 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22394132 | ||
| Pubmed | The RNase III enzyme DROSHA is essential for microRNA production and spermatogenesis. | 6.83e-06 | 3 | 53 | 2 | 22665486 | |
| Pubmed | A chemical genetic approach reveals distinct EphB signaling mechanisms during brain development. | 6.83e-06 | 3 | 53 | 2 | 23143520 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 32700178 | ||
| Pubmed | Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis. | 6.83e-06 | 3 | 53 | 2 | 26976605 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 30295958 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 26437240 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22434867 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22777876 | ||
| Pubmed | Complexity in regulation of microRNA machinery components in invasive breast carcinoma. | 6.83e-06 | 3 | 53 | 2 | 24574065 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22371183 | ||
| Pubmed | Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas. | 6.83e-06 | 3 | 53 | 2 | 26227789 | |
| Pubmed | Pineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR8. | 6.83e-06 | 3 | 53 | 2 | 32124011 | |
| Pubmed | Canonical and alternate functions of the microRNA biogenesis machinery. | 6.83e-06 | 3 | 53 | 2 | 20713509 | |
| Pubmed | Investigation of AID, Dicer, and Drosha Expressions in Patients with Chronic Lymphocytic Leukemia. | 6.83e-06 | 3 | 53 | 2 | 28388279 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 27173348 | ||
| Pubmed | EphB receptors couple dendritic filopodia motility to synapse formation. | 6.83e-06 | 3 | 53 | 2 | 18614029 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22766726 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 29731254 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 35025117 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 34855193 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 21788498 | ||
| Pubmed | Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. | 6.83e-06 | 3 | 53 | 2 | 21769619 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 25051176 | ||
| Pubmed | Transcript Level of MicroRNA Processing Elements in Gastric Cancer. | 6.83e-06 | 3 | 53 | 2 | 30168106 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 23663110 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22622783 | ||
| Pubmed | Retinal axon growth cones respond to EphB extracellular domains as inhibitory axon guidance cues. | 6.83e-06 | 3 | 53 | 2 | 11532925 | |
| Pubmed | Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus. | 6.83e-06 | 3 | 53 | 2 | 14691139 | |
| Pubmed | Ca2+ homeostasis maintained by TMCO1 underlies corpus callosum development via ERK signaling. | 8.47e-06 | 26 | 53 | 3 | 35927240 | |
| Pubmed | Dicer and Drosha expression in patients with nephrotic syndrome. | 1.36e-05 | 4 | 53 | 2 | 32412691 | |
| Pubmed | Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma. | 1.36e-05 | 4 | 53 | 2 | 22647351 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 20699384 | ||
| Pubmed | EphB2 receptor forward signaling controls cortical growth cone collapse via Nck and Pak. | 1.36e-05 | 4 | 53 | 2 | 23147113 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 32290861 | ||
| Pubmed | Ars2 maintains neural stem-cell identity through direct transcriptional activation of Sox2. | 1.36e-05 | 4 | 53 | 2 | 22198669 | |
| Pubmed | Eph receptor deficiencies lead to altered cochlear function. | 1.36e-05 | 4 | 53 | 2 | 12684184 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 22475621 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 26147304 | ||
| Pubmed | Multipotency of Adult Hippocampal NSCs In Vivo Is Restricted by Drosha/NFIB. | 1.36e-05 | 4 | 53 | 2 | 27545503 | |
| Pubmed | Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. | 1.36e-05 | 4 | 53 | 2 | 21804545 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 32770606 | ||
| Pubmed | GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking. | 1.36e-05 | 4 | 53 | 2 | 15965473 | |
| Pubmed | The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. | 2.27e-05 | 5 | 53 | 2 | 18288107 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 27045344 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 27880903 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 28576980 | ||
| Pubmed | Critical roles for EphB and ephrin-B bidirectional signalling in retinocollicular mapping. | 2.27e-05 | 5 | 53 | 2 | 21847105 | |
| Pubmed | The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. | 2.27e-05 | 5 | 53 | 2 | 18725527 | |
| Pubmed | Eph receptors are involved in the activity-dependent synaptic wiring in the mouse cerebellar cortex. | 2.27e-05 | 5 | 53 | 2 | 21559471 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 28716689 | ||
| Pubmed | Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. | 3.40e-05 | 6 | 53 | 2 | 19164858 | |
| Pubmed | Distribution of EphB receptors and ephrin-B1 in the developing vertebrate spinal cord. | 3.40e-05 | 6 | 53 | 2 | 16786562 | |
| Pubmed | Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning. | 3.40e-05 | 6 | 53 | 2 | 19182796 | |
| Cytoband | 16p13.11 | 1.38e-08 | 23 | 53 | 4 | 16p13.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 9.79e-06 | 426 | 53 | 6 | chr16p13 | |
| Cytoband | 15q21.3 | 7.59e-04 | 35 | 53 | 2 | 15q21.3 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.73e-04 | 14 | 32 | 2 | 1095 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 6.24e-04 | 21 | 32 | 2 | 680 | |
| GeneFamily | Ring finger proteins | 1.35e-03 | 275 | 32 | 4 | 58 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.46e-08 | 171 | 53 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-06 | 174 | 53 | 5 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-06 | 174 | 53 | 5 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-06 | 174 | 53 | 5 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | Influenza_Severe-Plasmablast|Influenza_Severe / Disease group and Cell class | 2.07e-06 | 175 | 53 | 5 | 3f9b9793d3d1b7a9b97899272b6a0d37b05c11d1 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.14e-05 | 151 | 53 | 4 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.39e-05 | 154 | 53 | 4 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.23e-05 | 163 | 53 | 4 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.44e-05 | 165 | 53 | 4 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.44e-05 | 165 | 53 | 4 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.76e-05 | 168 | 53 | 4 | 26aa96b2b547d11941cb803995ea3d302ee0518c | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-05 | 169 | 53 | 4 | a34aff9257ae9746226ee7af595c4678a4b0c896 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.99e-05 | 170 | 53 | 4 | 35e3945d8a540a3e2cec1b559316265aaad023d1 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.99e-05 | 170 | 53 | 4 | 0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.99e-05 | 170 | 53 | 4 | 0b5ddc7d452db0a389927a367914f7d257703f7e | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.10e-05 | 171 | 53 | 4 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.10e-05 | 171 | 53 | 4 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-05 | 172 | 53 | 4 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | URO-Lymphocyte-B-Plasmablast|URO / Disease, Lineage and Cell Type | 5.22e-05 | 172 | 53 | 4 | 48888ef50ac784b38aca81da68f8a94ce09c670d | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Reln_(Neuron.Gad1Gad2.Cplx3-Reln)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.29e-05 | 61 | 53 | 3 | 06aab3f1743ced1e46d22f0310f1cdb70c7a108e | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Reln_(Neuron.Gad1Gad2.Cplx3-Reln)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.29e-05 | 61 | 53 | 3 | fec6c9a4e12c260338856567bf547f914f473dbb | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.58e-05 | 175 | 53 | 4 | 553e68e8b439a2293efb969e1e2aa017ceb80daf | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.58e-05 | 175 | 53 | 4 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.58e-05 | 175 | 53 | 4 | 16d4e97271df1db9a0d167fc82a90d84d20dd1f2 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.58e-05 | 175 | 53 | 4 | 289d2aa7164bc02b1876b99f2fb67baa8e030c4e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.83e-05 | 177 | 53 | 4 | d2c1f46913ac00bbc0bb9320d5652edc01b34179 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.83e-05 | 177 | 53 | 4 | 65e090aad0ffb737ce034e25bd5b12a0b1dd9684 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.09e-05 | 179 | 53 | 4 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.23e-05 | 180 | 53 | 4 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.23e-05 | 180 | 53 | 4 | e4add4c94f892a2d93926e5c6dac6a738319d091 | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 6.36e-05 | 181 | 53 | 4 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 6.36e-05 | 181 | 53 | 4 | 3d7f089fb434fbc989f1fa159e22133ae00b2487 | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 6.36e-05 | 181 | 53 | 4 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | Control-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class (2021.01.30) | 6.64e-05 | 183 | 53 | 4 | e740f05536d1e4b2512811771928eb65f6696409 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 6.64e-05 | 183 | 53 | 4 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.64e-05 | 183 | 53 | 4 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | URO-Myeloid-pDC|URO / Disease, Lineage and Cell Type | 6.78e-05 | 184 | 53 | 4 | 0edb5dd003c2bca0b9e3ec18d03610d68bd52538 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-05 | 186 | 53 | 4 | 0096a61b1841784c913752b4f3639200446cc02c | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-05 | 186 | 53 | 4 | 6345777847960c71a2ba3ce5a49c72c34ebd0e73 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.07e-05 | 186 | 53 | 4 | d23c3318937492d7d665bec14253124c49181b5a | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-05 | 186 | 53 | 4 | 9e159ad7289dcae2ec7ce655df746f46801b81d3 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.83e-05 | 191 | 53 | 4 | 989bf108c7f2c78dd7f14481570f1819673a5469 | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.83e-05 | 191 | 53 | 4 | 3e7fbe4af2c23b3b964becde843d2f088ad41c23 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.83e-05 | 191 | 53 | 4 | bc2f3c4e71e3a55fe76ea03f45746329a8fc81da | |
| ToppCell | COVID-19-Lymphoid-pDC|COVID-19 / Condition, Lineage and Cell class | 7.83e-05 | 191 | 53 | 4 | 25343b11d42128ad16659e5519cd1673266cc505 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.99e-05 | 192 | 53 | 4 | d9ff2293358c8b031ba212021012e058014ff472 | |
| ToppCell | Severe_COVID-19-Myeloid-pDC|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.99e-05 | 192 | 53 | 4 | f79424c643a375dfe4579eff7ac1ba191e28a283 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.99e-05 | 192 | 53 | 4 | 2e8611d65090e39f1a6e74c972288e7b68376d15 | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.99e-05 | 192 | 53 | 4 | 43569726df281eebe57499e0993b9fd9d36118c2 | |
| ToppCell | medial-Hematologic-Plasmacytoid_Dendritic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.32e-05 | 194 | 53 | 4 | bb36274d6fe2d18c545a17d3809f331586502d01 | |
| ToppCell | medial-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.32e-05 | 194 | 53 | 4 | d58be6454a0795d6771036a1620553a153861615 | |
| ToppCell | medial-Hematologic-Plasmacytoid_Dendritic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.32e-05 | 194 | 53 | 4 | 0117cd68750153fd6b8978c8b4ce3589486d2b5f | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.49e-05 | 195 | 53 | 4 | fbc324c3435f32b9ca269d83333faecfe940d7fe | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.65e-05 | 196 | 53 | 4 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.65e-05 | 196 | 53 | 4 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-05 | 196 | 53 | 4 | 9c942bf9fc78caa173d2c7de5fe4c17f076c623b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.83e-05 | 197 | 53 | 4 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 8.83e-05 | 197 | 53 | 4 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.83e-05 | 197 | 53 | 4 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.18e-05 | 199 | 53 | 4 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | TCGA-Cervix-Primary_Tumor|TCGA-Cervix / Sample_Type by Project: Shred V9 | 9.18e-05 | 199 | 53 | 4 | ef6fde26af2ca9e6cde198ac0e14e03d9ab398f8 | |
| ToppCell | Sepsis-URO-Lymphocyte-B-Plasmablast|URO / Disease, condition lineage and cell class | 9.18e-05 | 199 | 53 | 4 | 0df6cafb7f3b607cbe80b6f25b4fd62d421d01ee | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-04 | 100 | 53 | 3 | 97ca9cda55a05fbb4d1f5d61f847c965e014f05c | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 4.33e-04 | 124 | 53 | 3 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Neuronal-Interneuron|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.43e-04 | 125 | 53 | 3 | eafc39072467e209c9fe3a4fa41cb09507a42e82 | |
| ToppCell | TCGA-Testes|World / Sample_Type by Project: Shred V9 | 4.75e-04 | 128 | 53 | 3 | a09b0e221b8749510002304e4d34d6a2eb8867e9 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.19e-04 | 132 | 53 | 3 | 560e836764ed7806fb18282dfebe434d30112a9a | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.19e-04 | 132 | 53 | 3 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | PBMC-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 5.31e-04 | 133 | 53 | 3 | e53fbd69775a4bff61de82557342f7ac80915c4d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells-neuroepithelial-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.31e-04 | 133 | 53 | 3 | bdaba11e8d9868eca57c3c976e381ee096d39ddf | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.55e-04 | 135 | 53 | 3 | 7e3559ed0fef7916d1938b4e1a9fa4456a60e3d3 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Agt_(Agt)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.55e-04 | 135 | 53 | 3 | 4cb399620aa9edc2ca59e4df76ab7011ceb58db9 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.55e-04 | 135 | 53 | 3 | 6bd2a0bfd8d20950f1b66810668682dc055a0ada | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Agt_(Agt)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.55e-04 | 135 | 53 | 3 | 97989546826bf3739e1b86a10832a457fd37c5d2 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.79e-04 | 137 | 53 | 3 | 6d90da42dcc06aa895f920218055068f3c76d57d | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.91e-04 | 138 | 53 | 3 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.56e-04 | 143 | 53 | 3 | 27e06327f96cb72bd111ea6ece6307e5ebb3a146 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.56e-04 | 143 | 53 | 3 | 4edef95ae2a1ef4fc4b0d4fadf75bfc54b583932 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-04 | 144 | 53 | 3 | cf9f049ab6cd80521598124f057c2debdde24788 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-04 | 144 | 53 | 3 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | TCGA-Uterus|World / Sample_Type by Project: Shred V9 | 6.69e-04 | 144 | 53 | 3 | 7efb45286ebf2dbfb9125fd6373f28dccb029a2e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-04 | 144 | 53 | 3 | b638398f559e7fd9d4294d1c830beeb20f905960 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-04 | 144 | 53 | 3 | 41eaeca54b3c39de417597267cbdb1f195dd885a | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 7.24e-04 | 148 | 53 | 3 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.39e-04 | 149 | 53 | 3 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-04 | 150 | 53 | 3 | 7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-04 | 150 | 53 | 3 | e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.97e-04 | 153 | 53 | 3 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.97e-04 | 153 | 53 | 3 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.97e-04 | 153 | 53 | 3 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | BAL-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 8.13e-04 | 154 | 53 | 3 | 0121d08cc527aed9b3e11ff62bb9012916f5c56b | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 8.59e-04 | 157 | 53 | 3 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.91e-04 | 159 | 53 | 3 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-04 | 159 | 53 | 3 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-04 | 159 | 53 | 3 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.91e-04 | 159 | 53 | 3 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-04 | 160 | 53 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-04 | 160 | 53 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.24e-04 | 161 | 53 | 3 | 7c9d4410d7142a5f3a05418c994f69978c9ffa17 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-04 | 162 | 53 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| Disease | phosphatidylcholine 40:7 measurement | 2.08e-04 | 13 | 49 | 2 | EFO_0021477 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.34e-04 | 181 | 49 | 4 | DOID:684 (is_implicated_in) | |
| Disease | dermatomyositis (is_marker_for) | 3.62e-04 | 17 | 49 | 2 | DOID:10223 (is_marker_for) | |
| Disease | eye colour measurement | 4.73e-04 | 218 | 49 | 4 | EFO_0009764 | |
| Disease | hair colour measurement | 5.23e-04 | 615 | 49 | 6 | EFO_0007822 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 6.03e-04 | 99 | 49 | 3 | EFO_0004639, EFO_0008595 | |
| Disease | Brain Diseases | 7.91e-04 | 25 | 49 | 2 | C0006111 | |
| Disease | Encephalopathies | 9.23e-04 | 27 | 49 | 2 | C0085584 | |
| Disease | non-melanoma skin carcinoma | 9.81e-04 | 265 | 49 | 4 | EFO_0009260 | |
| Disease | Bilateral Wilms Tumor | 1.07e-03 | 29 | 49 | 2 | C2930471 | |
| Disease | cortical surface area measurement | 1.56e-03 | 1345 | 49 | 8 | EFO_0010736 | |
| Disease | Nephroblastoma | 1.64e-03 | 36 | 49 | 2 | C0027708 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CVVPCDPVPACMSPH | 321 | Q9H161 | |
| FQMHPLYKCTQPPCP | 181 | Q969M2 | |
| FPPPHLEDNMLCPKC | 276 | Q7L190 | |
| AQMHLLPSPPEPRLC | 4381 | Q96M86 | |
| CLKIPPRCMFDHPDA | 1641 | Q9UPY3 | |
| PPECVCSLPFHPQRM | 331 | Q9UND3 | |
| YRLPPPMDCPAALHQ | 841 | P54762 | |
| NPCPMDSRPCRHLPK | 321 | Q53RD9 | |
| FPTPPASQPLCLCME | 71 | C9J6K1 | |
| CRQCHLTTPIMFPPE | 1416 | O95714 | |
| MTFPQLGPVQPIPCC | 636 | Q8NI77 | |
| LPQQPLHPCMFPLAT | 306 | P49005 | |
| MRQVCCSALPPPPLE | 1 | O14511 | |
| PPCVNPGNPVFSCML | 26 | H3BRN8 | |
| RLPPPMDCPTALHQL | 856 | P54753 | |
| IELPINLPPPCRCMH | 4371 | P98164 | |
| PPKCVCSLPFHPQRM | 331 | F8WFD2 | |
| PKCVCSLPFHPQRMI | 351 | E9PIF3 | |
| CTICQMPPPPHLSAL | 241 | Q7RTU3 | |
| APPAPCQCPRVESSM | 1736 | Q13698 | |
| HLMNPEYVPKPCCAP | 466 | P22004 | |
| EPPCNDPMVCRLPVS | 86 | Q9UBX1 | |
| EDPCCPLHFQLPPQM | 356 | Q9H9L4 | |
| MLEPPFCPDPHAVYC | 461 | P32298 | |
| PECVCSLPFHPQRMI | 351 | E9PJI5 | |
| PECVCSLPFHPQRMI | 351 | P0DM63 | |
| IMSCCPDPNPPIHKI | 276 | Q96P20 | |
| SHVHCPLPMRFLQCP | 446 | Q92521 | |
| DSPPCCPRFHFMPRF | 671 | Q9NRR4 | |
| QHLPVCSVPPPMLQA | 236 | Q9H0F5 | |
| PPECVCSLPFHPQRM | 331 | E9PKD4 | |
| PRCPEHCPMPTLCTQ | 656 | Q9BRB3 | |
| ECPMECFCPPSFPTA | 41 | O60938 | |
| SCCKEPLADPPPMRH | 186 | Q8NAX2 | |
| CLPTPKCHTPPLYRM | 16 | Q02543 | |
| IHCPPYQNDCGRMPR | 796 | O94875 | |
| ARPPSHMDLCNPQPC | 686 | Q15468 | |
| PEMPHEPLACANLPR | 606 | Q8N2C7 | |
| PFPCPECGRRFMQPV | 111 | Q96K58 | |
| PQPMAPRELPTCSIC | 46 | Q9ULX5 | |
| PPAMPRLPSCCPQHS | 471 | Q6ZNA4 | |
| WNCPPVGLSPMHFPC | 96 | Q9NR96 | |
| APNPCMECPRHFPQL | 261 | Q9NR96 | |
| MFSGQHYPLCCLPPP | 141 | Q7L0R7 | |
| APAPHCEMSRFVPLP | 86 | O15533 | |
| NLPPSMCDYRHEPLC | 56 | Q96PS6 | |
| CSNDPPCFSVMIPPN | 851 | Q92626 | |
| PCPHPGCNKVFMIDR | 466 | Q8N554 | |
| DLPLMALPPCHALCQ | 186 | P04818 | |
| QLMPHIFAHCIPPSC | 356 | Q8IYQ7 | |
| CEFSPPMVLPRTSPC | 1111 | O94813 | |
| KLAHTPAPPPTCYMC | 3106 | Q96JG9 | |
| ACPEFCNPRQSPMNP | 146 | A8K8V0 | |
| WREPHFCPMACPPNS | 1416 | Q9Y493 | |
| APRPADKCMPCSCHP | 856 | Q9Y6N6 |